Abbott Laboratories
About
Abbott Laboratories (NYSE: ABT) is a diversified global healthcare company with leading positions across four major segments: medical devices (including continuous glucose monitors under the FreeStyle Libre brand), diagnostics, nutritional products (including Ensure and Similac), and established pharmaceuticals sold in emerging markets. The company's FreeStyle Libre continuous glucose monitoring system has become a transformational growth driver, rapidly gaining market share as diabetes management shifts toward continuous monitoring for both insulin-dependent and non-insulin-dependent patients. Abbott offers investors a well-balanced healthcare portfolio with multiple growth catalysts, a strong track record of over 50 consecutive years of dividend increases as a Dividend Aristocrat, and significant exposure to faster-growing emerging markets across all business segments.
Aging Population Stocks
Abbott's diversified healthcare portfolio spanning medical devices, diagnostics, nutrition, and pharmaceuticals positions it as a key beneficiary of aging population trends worldwide.
Healthcare Stocks
Abbott Laboratories is a diversified healthcare stock with leading positions in medical devices, diagnostics, nutrition, and pharmaceuticals, offering investors balanced exposure to multiple healthcare growth drivers anchored by its fast-growing FreeStyle Libre glucose monitoring franchise and a decades-long track record of dividend increases.
Key Financials ABT
Price
$112.68
Change (1D)
+1.09%
Change (30D)
-10.06%
Change (60D)
-13.34%
Change (90D)
-15.75%
Change (180D)
-14.65%
Change (1Y)
-13.65%
Change (5Y)
-9.96%
P/E Ratio
20.83
EPS (TTM)
$5.41
52-Week Range
$105.27 — $141.23
50-Day MA
$119.58
Volume
7.70M
Data updated Feb 15 · Source: Twelve Data
